Global Osteoarthritis Treatment Market 2022-2028

December 2022 | 71 pages | ID: GB3C9E835B52EN
Gen Consulting Company

Abstracts

According to latest analysis by Gen Consulting Company, the global osteoarthritis treatment market is poised to grow by USD 2.3 billion during 2022-2028, progressing at a CAGR of 5.3% during the forecast period.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global osteoarthritis treatment market. It traces the market’s historic and forecast market growth. The report identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches. This study also provides an analysis of the impact of the COVID-19 crisis on the osteoarthritis treatment industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the drug, anatomy, and region. The global market for osteoarthritis treatment can be segmented by drug: non-steroidal anti-inflammatory drug (NSAID), corticosteroid, hyaluronic acid injection, others. According to the research, the non-steroidal anti-inflammatory drug (NSAID) segment had the largest share in the global osteoarthritis treatment market. Osteoarthritis treatment market is further segmented by anatomy: ankle osteoarthritis, hip osteoarthritis, knee osteoarthritis, shoulder osteoarthritis, others. In 2021, the knee osteoarthritis segment made up the largest share of revenue generated by the osteoarthritis treatment market. Based on region, the osteoarthritis treatment market is segmented into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. Among these, North America was accounted for the highest revenue generator in 2021.

Market Segmentation

By drug: non-steroidal anti-inflammatory drug (NSAID), corticosteroid, hyaluronic acid injection, others

By anatomy: ankle osteoarthritis, hip osteoarthritis, knee osteoarthritis, shoulder osteoarthritis, others

By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report explores the recent developments and profiles of key vendors in the Global Osteoarthritis Treatment Market, including Abbott Laboratories, Anika Therapeutics Inc., Assertio Holdings Inc., Bayer AG, Glaxosmithkline plc, Mylan N.V., Novartis AG, Pfizer Inc., Sanofi SA, Zimmer Biomet Holdings, Inc., among others.

*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period

This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report

• To analyze and forecast the market size of the global osteoarthritis treatment market.
• To classify and forecast the global osteoarthritis treatment market based on drug, anatomy, region.
• To identify drivers and challenges for the global osteoarthritis treatment market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global osteoarthritis treatment market.
• To identify and analyze the profile of leading players operating in the global osteoarthritis treatment market.

Why Choose This Report

• Gain a reliable outlook of the global osteoarthritis treatment market forecasts from 2022 to 2028 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Contents

PART 1. INTRODUCTION

Report description
Objectives of the study
Market segment
Years considered for the report
Currency
Key target audience

PART 2. METHODOLOGY

PART 3. EXECUTIVE SUMMARY

PART 4. MARKET OVERVIEW

Introduction
Drivers
Restraints
Impact of COVID-19 pandemic

PART 5. MARKET BREAKDOWN BY DRUG

Non-steroidal anti-inflammatory drug (NSAID)
Corticosteroid
Hyaluronic acid injection
Others

PART 6. MARKET BREAKDOWN BY ANATOMY

Ankle osteoarthritis
Hip osteoarthritis
Knee osteoarthritis
Shoulder osteoarthritis
Others

PART 7. MARKET BREAKDOWN BY REGION

North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America

PART 8. KEY COMPANIES

Abbott Laboratories
Anika Therapeutics Inc.
Assertio Holdings Inc.
Bayer AG
Glaxosmithkline plc
Mylan N.V.
Novartis AG
Pfizer Inc.
Sanofi SA
Zimmer Biomet Holdings, Inc.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES
DISCLAIMER